Wedbush Equities Analysts Lower Earnings Estimates for HOWL
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Free Report) – Investment analysts at Wedbush decreased their FY2025 earnings estimates for Werewolf Therapeutics in a research note issued to investors on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.84) for the year, down from their prior estimate […]
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Free Report) – Investment analysts at Wedbush decreased their FY2025 earnings estimates for Werewolf Therapeutics in a research note issued to investors on Wednesday, March 12th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.84) for the year, down from their prior estimate […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
